Fulgent Genetics EBITDA 2015-2024 | FLGT

Fulgent Genetics ebitda from 2015 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Fulgent Genetics Annual EBITDA
(Millions of US $)
2023 $-53
2022 $216
2021 $695
2020 $294
2019 $2
2018 $-3
2017 $-1
2016 $2
2015 $-4
2014 $-1
Fulgent Genetics Quarterly EBITDA
(Millions of US $)
2024-06-30 $-14
2024-03-31 $-16
2023-12-31 $-26
2023-09-30 $5
2023-06-30 $-14
2023-03-31 $-18
2022-12-31 $-26
2022-09-30 $11
2022-06-30 $22
2022-03-31 $209
2021-12-31 $156
2021-09-30 $165
2021-06-30 $103
2021-03-31 $270
2020-12-31 $228
2020-09-30 $64
2020-06-30 $3
2020-03-31 $-1
2019-12-31 $0
2019-09-30 $2
2019-06-30 $1
2019-03-31 $-1
2018-12-31 $-0
2018-09-30 $-0
2018-06-30 $-0
2018-03-31 $-2
2017-12-31 $-2
2017-09-30 $-1
2017-06-30 $0
2017-03-31 $1
2016-12-31 $2
2016-09-30 $-0
2016-06-30 $1
2016-03-31 $-0
2015-12-31
2015-09-30 $1
2015-06-30
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.613B $0.289B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $11.978B 0.00
Inspire Medical Systems (INSP) United States $6.055B 188.82
Hims & Hers Health (HIMS) United States $5.988B 154.89
Axonics (AXNX) United States $3.602B 1762.00
IRhythm Technologies (IRTC) United States $2.783B 0.00
Privia Health (PRVA) United States $2.736B 228.00
Enovis (ENOV) United States $2.646B 17.94
Omnicell (OMCL) United States $2.263B 74.03
Azenta (AZTA) United States $2.242B 127.33
10x Genomics (TXG) United States $1.925B 0.00
Clover Health Investments (CLOV) United States $1.657B 0.00
Schrodinger (SDGR) United States $1.422B 0.00
Phreesia (PHR) United States $1.252B 0.00
Standard BioTools (LAB) United States $0.830B 0.00
Talkspace (TALK) United States $0.586B 0.00
Butterfly Network (BFLY) United States $0.582B 0.00
Definitive Healthcare (DH) United States $0.508B 88.00
Health Catalyst (HCAT) United States $0.506B 0.00
Pulmonx (LUNG) United States $0.298B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.248B 0.00
TruBridge (TBRG) United States $0.214B 62.22
P3 Health Partners (PIII) United States $0.142B 0.00
American Well (AMWL) United States $0.139B 0.00
EUDA Health Holdings (EUDA) Singapore $0.106B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.064B 0.00
111 (YI) China $0.057B 0.00
Zepp Health (ZEPP) China $0.050B 0.00
Outset Medical (OM) United States $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
CareCloud (CCLD) United States $0.042B 0.00
Movano (MOVE) United States $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
MSP Recovery (LIFW) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00